Fierce Pharma
SEPTEMBER 5, 2024
AstraZeneca has found its employees’ practices under the microscope of Chinese law enforcement years after an insurance fraud case. | AstraZeneca has found its employees’ practices under the microscope of Chinese law enforcement years after an insurance fraud case.
MedCity News
SEPTEMBER 5, 2024
Cyril Philip, vice president of digital health ventures with Bon Secours Mercy Health and digital ventures lead for Accrete Health Partners, is taking part in a panel discussion at INVEST Digital Health in Dallas on September 18. In response to emailed questions, he addressed some of these challenges. The post What Challenges Do Implementing New Tech at a Hospital Pose?
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
SEPTEMBER 5, 2024
Johnson & Johnson’s newly FDA-approved lung cancer combination of Rybrevant and Lazcluze is inching ever closer to a statistically significant survival showing, which could help it better chall | Johnson & Johnson’s newly FDA-approved lung cancer combination of Rybrevant and Lazcluze is inching ever closer to a statistically significant survival showing, which could help it better challenge AstraZeneca’s Tagrisso.
MedCity News
SEPTEMBER 5, 2024
Omada Health is a respected health tech company but what do customers see it? A flesh and blood and an AI analysis follows. The post What Do Consumers and AI Think Of Omada Health? appeared first on MedCity News.
Advertiser: ZoomInfo
AI adoption is reshaping sales and marketing. But is it delivering real results? We surveyed 1,000+ GTM professionals to find out. The data is clear: AI users report 47% higher productivity and an average of 12 hours saved per week. But leaders say mainstream AI tools still fall short on accuracy and business impact. Download the full report today to see how AI is being used — and where go-to-market professionals think there are gaps and opportunities.
Fierce Pharma
SEPTEMBER 5, 2024
With dwindling funds after a prior snub from the FDA, ImmunityBio’s journey to bag approval for its Merck-rivaling bladder cancer drug Anktiva wasn’t easy. | The drugmaker laid off 20 employees as it attempts to recoup from dwindling funds during its Anktiva launch in bladder cancer.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
Fierce Pharma
SEPTEMBER 5, 2024
After handing over $30 million in criminal penalties last summer, Glenmark Pharmaceuticals has agreed to settle with the U.S. | Glenmark will pay the U.S. Department of Justice $25 million to resolve claims that it worked with other drugmakers to rig prices of the cholesterol med pravastatin. The case forms part of a larger antitrust probe implicating numerous manufacturers.
MedCity News
SEPTEMBER 5, 2024
Samsung announced its plans to acquire French medtech startup Sonio. The startup’s AI platform, which was cleared by the FDA last year, automates ultrasound reporting so that healthcare providers can conduct these exams with greater accuracy and efficiency. The post Samsung Acquires AI-Powered Prenatal Ultrasound Startup appeared first on MedCity News.
Fierce Pharma
SEPTEMBER 5, 2024
After running up against a roadblock earlier this summer, the controversial BIOSECURE Act could gain new momentum next week. | Next week, the U.S. House of Representatives is slated to consider the BIOSECURE Act, which was introduced in January and seeks to halt federal contracts with certain Chinese biotech equipment and service providers over national security concerns.
MedCity News
SEPTEMBER 5, 2024
Dr. Tina Saw is the founder and CEO of Oral Genome, a healthcare startup that’s developing saliva tests to detect and prevent oral diseases. In response to emailed questions, Saw talked about her company’s approach. The post This Diagnostic Startup Uses Saliva to Detect Oral Diseases Earlier appeared first on MedCity News.
Speaker: Jesse Hunter and Brynn Chadwick
Today’s buyers expect more than generic outreach–they want relevant, personalized interactions that address their specific needs. For sales teams managing hundreds or thousands of prospects, however, delivering this level of personalization without automation is nearly impossible. The key is integrating AI in a way that enhances customer engagement rather than making it feel robotic.
Pharma IQ
SEPTEMBER 5, 2024
Explore how digital transformation, particularly cloud technology and AI enhances efficiency and patient outcomes.
MedCity News
SEPTEMBER 5, 2024
Let’s envision a healthcare system where caregiving is valued as the essential work it is. Where technology and policy work hand in hand and no one has to choose between caring for a loved one and pursuing their own health and career goals. The post While America Rested on Labor Day, The Invisible Healthcare Workforce Carried On appeared first on MedCity News.
pharmaphorum
SEPTEMBER 5, 2024
A "small number" of AstraZeneca employees have been detained in China in an investigation into suspected data privacy and drug import breaches
MedCity News
SEPTEMBER 5, 2024
Positive preliminary results for Eli Lilly’s efsitora alfa continue to build the case for this once-weekly insulin in type 2 diabetes patients. Lilly is trying to catch up to Novo Nordisk’s once weekly insulin icodec, which is commercially available in several markets around the world but is not yet approved by the FDA. The post Eli Lilly Moves Closer to Bringing Diabetes Patients a Once-Weekly Insulin Alternative appeared first on MedCity News.
Advertiser: ZoomInfo
ZoomInfo customers aren’t just selling — they’re winning. Revenue teams using our Go-To-Market Intelligence platform grew pipeline by 32%, increased deal sizes by 40%, and booked 55% more meetings. Download this report to see what 11,000+ customers say about our Go-To-Market Intelligence platform and how it impacts their bottom line. The data speaks for itself!
Fierce Pharma
SEPTEMBER 5, 2024
Insights from Planning Committee Member Shirish Ingawale | Why is PDA’s Universe of Pre-Filled Syringes and Injection Devices Conference the must-attend event of the year? Get an exclusive preview from expert Shirish Ingawale!
MedCity News
SEPTEMBER 5, 2024
Switching to a new transportation management vendor can bring much-needed relief to member populations and plan staff managing the programs. Here are few tips to help make the transition easier. The post Three Critical Steps to Ensure Health Plans’ Smooth Transition of Transportation Management Services appeared first on MedCity News.
Fierce Pharma
SEPTEMBER 5, 2024
By adding $1.1 billion to its settlement proposal, Johnson & Johnson is inching closer to resolving approximately 62,000 personal injury lawsuits from those who claim their cancers were caused | By adding $1.1 billion to its settlement proposal, Johnson & Johnson is inching closer to resolving approximately 62,000 personal injury lawsuits from those who claim their cancers were caused by the company’s talcum powder products.
PharmaVoice
SEPTEMBER 5, 2024
Cristal Downing is helping Merck & Co. buck pharma’s zipped-lip status quo and usher in a “new era” of openness, transparency and “overt communication.
Speaker: Kevin Burke
AI is reshaping marketing and sales, empowering professionals to work smarter, faster, and more effectively. This webinar will provide a practical introduction to AI, focusing on its current applications, transformative potential, and strategies for successful implementation in your organization. Using real-world examples and actionable insights, we’ll examine how businesses are leveraging AI to increase efficiency, enhance personalization, and drive measurable results.
pharmaphorum
SEPTEMBER 5, 2024
Listen to the podcast interview with Manny Belabe from ArisGlobal as he discusses The Life Sciences Generative AI Council and its role in creating a sustainable technological future. Gain insights into the future of AI in life sciences.
PharmaTimes
SEPTEMBER 5, 2024
Pre-clinical data of VTX-806 in demonstrated normalisation of metabolic parameters
PharmaTech
SEPTEMBER 5, 2024
Qualifying material suppliers is a crucial step in ensuring safe and effective drug products.
PharmaTimes
SEPTEMBER 5, 2024
New biomarker test aims to improve early-stage melanoma treatment
Advertiser: ZoomInfo
Incorporating generative AI (gen AI) into your sales process can speed up your wins through improved efficiency, personalized customer interactions, and better informed decision- making. Gen AI is a game changer for busy salespeople and can reduce time-consuming tasks, such as customer research, note-taking, and writing emails, and provide insightful data analysis and recommendations.
pharmaphorum
SEPTEMBER 5, 2024
EU General Court suspends decision to revoke the license for Advanz Pharma's primary biliary cholangitis drug Ocaliva.
European Pharmaceutical Review
SEPTEMBER 5, 2024
The Medicines and Healthcare Products Regulatory Agency (MHRA) has licenced the first treatment (oral gonadotropin-releasing hormone [GnRH] receptor antagonist) in a new class of medicines for women in the UK with endometriosis. Relugolix combination therapy, Ryeqo (relugolix 40mg, estradiol 1mg, and norethisterone acetate 0.5mg), is authorised to treat endometriosis symptoms in adults.
pharmaphorum
SEPTEMBER 5, 2024
ArsenalBio raises $325m for programmable CAR-T platform Phil.
Pharmaceutical Commerce
SEPTEMBER 5, 2024
In the second part of her interview with Pharma Commerce Editor Nicholas Saraceno, Ilisa B.G. Bernstein, President of Bernstein Rx Solutions, LLC, discusses the best practices that compliance teams should consider as the end of the stabilization period approaches this November.
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
pharmaphorum
SEPTEMBER 5, 2024
Click Therapeutics' digital therapeutic for migraine clears late-stage study using an endpoint used to test drugs, clearing the way for regulatory filing.
Pharmaceutical Commerce
SEPTEMBER 5, 2024
Business strategies and top news in the biotech / biopharma industry, including market access, supply chain distribution and more.
pharmaphorum
SEPTEMBER 5, 2024
J&J is reported to have raised its offer to settle claims that its talc products caused cancer by $1.1bn, as it reaches agreement with a holdout law firm.
Expert insights. Personalized for you.
363 
Let's personalize your content